JD

Jayanti Dawra

Active Director Director DIN 08315697
DIN 08315697 First appointment Dec 2018 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Dec 2018
Shareholding value Locked Premium profile

About Jayanti Dawra

Jayanti Dawra has 7 years in corporate governance. Holds Director role. Currently with 1 company, including Dawchem Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08315697
Primary Designation Director
First Appointment 28 Dec 2018
Oldest Company Age 7 yrs

Current companies

Company Designation Appointment Founded Status
Director 28 Dec 2018 2018 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Dawchem Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Jayanti Dawra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jayanti Dawra

Jayanti Dawra has 7 years in corporate governance. Holds Director role. Currently with 1 company, including Dawchem Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Jayanti Dawra is associated with 1 company as Director.

Jayanti Dawra has expertise in General Business.

Jayanti Dawra has 7 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available